Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766)
Nicola E.A Chessum
1
,
Swee Y. Sharp
1
,
John J. Caldwell
1
,
A Elisa Pasqua
1
,
Birgit Wilding
1
,
Giampiero Colombano
1
,
Ian M. Collins
1
,
Bugra Ozer
1
,
Meirion Richards
1
,
Martin Rowlands
1
,
Mark Stubbs
1
,
Rosemary Burke
1
,
P. Craig McAndrew
1
,
Paul Clarke
1
,
Paul Workman
1
,
Matthew D Cheeseman
1
,
K JONES
1
1
Cancer Research
UK Cancer Therapeutics Unit at The Institute of Cancer Research, London SW7 3RP, United Kingdom
|
Publication type: Journal Article
Publication date: 2018-01-05
scimago Q1
wos Q1
SJR: 1.801
CiteScore: 11.5
Impact factor: 6.8
ISSN: 00222623, 15204804
PubMed ID:
29240418
Drug Discovery
Molecular Medicine
Abstract
Demonstrating intracellular protein target engagement is an essential step in the development and progression of new chemical probes and potential small molecule therapeutics. However, this can be particularly challenging for poorly studied and noncatalytic proteins, as robust proximal biomarkers are rarely known. To confirm that our recently discovered chemical probe 1 (CCT251236) binds the putative transcription factor regulator pirin in living cells, we developed a heterobifunctional protein degradation probe. Focusing on linker design and physicochemical properties, we generated a highly active probe 16 (CCT367766) in only three iterations, validating our efficient strategy for degradation probe design against nonvalidated protein targets.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
|
|
|
ACS Medicinal Chemistry Letters
5 publications, 5.68%
|
|
|
European Journal of Medicinal Chemistry
4 publications, 4.55%
|
|
|
Journal of Medicinal Chemistry
3 publications, 3.41%
|
|
|
Drug Discovery Today
3 publications, 3.41%
|
|
|
Medicinal Research Reviews
3 publications, 3.41%
|
|
|
ACS Chemical Biology
3 publications, 3.41%
|
|
|
Future Medicinal Chemistry
2 publications, 2.27%
|
|
|
Frontiers in Chemistry
2 publications, 2.27%
|
|
|
Drug Discovery Today: Technologies
2 publications, 2.27%
|
|
|
Cell Chemical Biology
2 publications, 2.27%
|
|
|
MedChemComm
2 publications, 2.27%
|
|
|
Chemical Communications
2 publications, 2.27%
|
|
|
Expert Opinion on Drug Discovery
2 publications, 2.27%
|
|
|
Exploration of Targeted Anti-tumor Therapy
2 publications, 2.27%
|
|
|
Molecular Biology
1 publication, 1.14%
|
|
|
Future Drug Discovery
1 publication, 1.14%
|
|
|
Molecules
1 publication, 1.14%
|
|
|
Acta Biochimica et Biophysica Sinica
1 publication, 1.14%
|
|
|
Molecular Cancer
1 publication, 1.14%
|
|
|
Nature
1 publication, 1.14%
|
|
|
Signal Transduction and Targeted Therapy
1 publication, 1.14%
|
|
|
Nature Chemistry
1 publication, 1.14%
|
|
|
Nature Structural and Molecular Biology
1 publication, 1.14%
|
|
|
Targeted Oncology
1 publication, 1.14%
|
|
|
Cancer Letters
1 publication, 1.14%
|
|
|
Bioorganic and Medicinal Chemistry Letters
1 publication, 1.14%
|
|
|
Molecular Cell
1 publication, 1.14%
|
|
|
Trends in Cancer
1 publication, 1.14%
|
|
|
Trends in Pharmacological Sciences
1 publication, 1.14%
|
|
|
1
2
3
4
5
|
Publishers
|
5
10
15
20
25
|
|
|
Elsevier
23 publications, 26.14%
|
|
|
American Chemical Society (ACS)
14 publications, 15.91%
|
|
|
Wiley
14 publications, 15.91%
|
|
|
Springer Nature
10 publications, 11.36%
|
|
|
Royal Society of Chemistry (RSC)
6 publications, 6.82%
|
|
|
Taylor & Francis
5 publications, 5.68%
|
|
|
Cold Spring Harbor Laboratory
3 publications, 3.41%
|
|
|
Frontiers Media S.A.
2 publications, 2.27%
|
|
|
Oxford University Press
2 publications, 2.27%
|
|
|
Open Exploration Publishing
2 publications, 2.27%
|
|
|
Pleiades Publishing
1 publication, 1.14%
|
|
|
Newlands Press Ltd
1 publication, 1.14%
|
|
|
MDPI
1 publication, 1.14%
|
|
|
SAGE
1 publication, 1.14%
|
|
|
King Saud University
1 publication, 1.14%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
88
Total citations:
88
Citations from 2024:
10
(11.37%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Chessum N. E. et al. Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766) // Journal of Medicinal Chemistry. 2018. Vol. 61. No. 3. pp. 918-933.
GOST all authors (up to 50)
Copy
Chessum N. E., Sharp S. Y., Caldwell J. J., Pasqua A. E., Wilding B., Colombano G., Collins I. M., Ozer B., Richards M., Rowlands M., Stubbs M., Burke R., McAndrew P. C., Clarke P., Workman P., Cheeseman M. D., JONES K. Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766) // Journal of Medicinal Chemistry. 2018. Vol. 61. No. 3. pp. 918-933.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1021/acs.jmedchem.7b01406
UR - https://doi.org/10.1021/acs.jmedchem.7b01406
TI - Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766)
T2 - Journal of Medicinal Chemistry
AU - Chessum, Nicola E.A
AU - Sharp, Swee Y.
AU - Caldwell, John J.
AU - Pasqua, A Elisa
AU - Wilding, Birgit
AU - Colombano, Giampiero
AU - Collins, Ian M.
AU - Ozer, Bugra
AU - Richards, Meirion
AU - Rowlands, Martin
AU - Stubbs, Mark
AU - Burke, Rosemary
AU - McAndrew, P. Craig
AU - Clarke, Paul
AU - Workman, Paul
AU - Cheeseman, Matthew D
AU - JONES, K
PY - 2018
DA - 2018/01/05
PB - American Chemical Society (ACS)
SP - 918-933
IS - 3
VL - 61
PMID - 29240418
SN - 0022-2623
SN - 1520-4804
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2018_Chessum,
author = {Nicola E.A Chessum and Swee Y. Sharp and John J. Caldwell and A Elisa Pasqua and Birgit Wilding and Giampiero Colombano and Ian M. Collins and Bugra Ozer and Meirion Richards and Martin Rowlands and Mark Stubbs and Rosemary Burke and P. Craig McAndrew and Paul Clarke and Paul Workman and Matthew D Cheeseman and K JONES},
title = {Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766)},
journal = {Journal of Medicinal Chemistry},
year = {2018},
volume = {61},
publisher = {American Chemical Society (ACS)},
month = {jan},
url = {https://doi.org/10.1021/acs.jmedchem.7b01406},
number = {3},
pages = {918--933},
doi = {10.1021/acs.jmedchem.7b01406}
}
Cite this
MLA
Copy
Chessum, Nicola E.A, et al. “Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766).” Journal of Medicinal Chemistry, vol. 61, no. 3, Jan. 2018, pp. 918-933. https://doi.org/10.1021/acs.jmedchem.7b01406.